HERBALIFE INTERNATIONAL INC
10-Q, 1996-05-15
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: GROWTH HOTEL INVESTORS II, 10-Q, 1996-05-15
Next: LINEAR TECHNOLOGY CORP /CA/, 10-Q, 1996-05-15



<PAGE>

================================================================================

                                UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549

                                  FORM 10-Q
(Mark One)

/ X /  QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE 
       ACT OF 1934 (FEE REQUIRED)

For the quarterly period ended MARCH 31, 1996

                                      OR

/   /  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES 
       EXCHANGE  ACT OF 1934 (NO FEE REQUIRED)

For the transition period from __________________ to ___________________________

                        Commission file number 0-15712

                        HERBALIFE INTERNATIONAL, INC.
                        -----------------------------
            (Exact name of Registrant as specified in its charter)

            Nevada                                         22-2695420
  -------------------------------                       ----------------------
  (State or other jurisdiction of                       (I.R.S. Employer
  incorporation or organization)                        Identification Number)

  1800 Century Park East, Los Angeles, California             90067
  -----------------------------------------------           ----------
  (Address of principal executive offices)                  (Zip Code)

                                (310) 410-9600
                                --------------
             (Registrant's telephone number, including area code)

- --------------------------------------------------------------------------------
             (Former Name, Former Address and Former Fiscal Year,
                         If Changed Since Last Report

Indicate by check mark whether the Registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months (or for such shorter period that the 
Registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days.
                             Yes   X    No      
                                 -----     -----

            APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY
                 PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

Indicate by check mark whether the registrant has filed all documents and 
reports required to be filed by Sections 12, 13, or 15(d) of the Securities 
Exchange Act of 1934 subsequent to the distribution of securities under a 
plan confirmed by a court.
                             Yes        No      
                                 -----     -----

                    APPLICABLE ONLY TO CORPORATE ISSUERS:


The number of shares outstanding of each of the registrant's classes of 
Common Stock, as of May 2, 1996: 29,751,864.


================================================================================

<PAGE>
                        HERBALIFE INTERNATIONAL, INC.
                  Index to Financial Statements and Exhibits
         Filed with the Quarterly Report of the Company on Form 10-Q
                  For the Three Months Ended March 31, 1996



                        PART I.  FINANCIAL INFORMATION

Item 1.   Financial Statements:                                  Page No.
                                                                 --------
          Consolidated Balance Sheets                                2

          Consolidated Statements of Income                          3

          Consolidated Statements of Cash Flows                      4

          Notes to Consolidated Financial Statements                 5

Item 2.   Management's Discussion and Analysis of Financial 
          Condition and Results of Operations                      6-8

                         PART II.  OTHER INFORMATION

Item 1.   Legal Proceedings                                          9

Item 2.   Changes in Securities                                      9

Item 3.   Defaults Upon Senior Securities                            9

Item 4.   Submission of Matters to a Vote of Security Holders        9

Item 5.   Other Information                                          9

Item 6.   Exhibits and Reports on Form 8-K                        9-11

Signature                                                           12


<PAGE>

                        PART I.  FINANCIAL INFORMATION

Item 1.  FINANCIAL STATEMENTS

                        HERBALIFE INTERNATIONAL, INC.
                         CONSOLIDATED BALANCE SHEETS
                                 (Unaudited)

                                    ASSETS

                                             December 31,          March 31,
                                                 1995                1996
                                             ------------         ------------
CURRENT ASSETS:
Cash and cash equivalents                    $ 69,176,000         $ 65,348,000
Marketable securities                          35,050,000           31,420,000
Receivables                                    18,617,000           19,494,000
Inventories                                    40,904,000           43,170,000
Prepaid income taxes                            1,457,000
Prepaid expenses and other current assets       5,763,000            7,646,000
Deferred income taxes                           7,818,000            7,465,000
                                             ------------         ------------
Total current assets                          178,785,000          174,543,000
                                             ------------         ------------

PROPERTY - at cost                             39,637,000           42,288,000
Less accumulated depreciation and 
  amortization                                (23,036,000)         (24,293,000)
                                             ------------         ------------
                                               16,601,000           17,995,000
                                             ------------         ------------

OTHER ASSETS                                    8,500,000            6,727,000
GOODWILL, net of accumulated amortization 
  of $1,083,000 (1995) and $1,126,000 
  (1996)                                        3,804,000            3,761,000
                                             ------------         ------------
TOTAL                                        $207,690,000         $203,026,000
                                             ------------         ------------
                                             ------------         ------------


                     LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
Accounts payable                             $ 18,667,000         $ 16,441,000
Royalty overrides                              32,366,000           27,612,000
Accrued expenses                               17,275,000           24,411,000
Dividends payable                               4,542,000            4,465,000
Current portion of bank loans and 
  contracts payable                             1,185,000            1,176,000
Advance sales deposits                         16,572,000            8,937,000
Income taxes payable                            3,052,000            3,319,000
                                             ------------         ------------
Total current liabilities                      93,659,000           86,361,000
                                             ------------         ------------
BANK LOANS AND CONTRACTS PAYABLE                1,779,000            1,533,000
                                             ------------         ------------
DEFERRED INCOME TAXES                           2,722,000            3,077,000
                                             ------------         ------------
STOCKHOLDERS' EQUITY:
Common stock, $.01 par value; authorized 
  100,000,000 shares, issued 29,887,864 
  (1995) and 29,751,864 (1996) shares             300,000              299,000
Paid-in-capital in excess of par value         40,417,000           38,802,000
Retained earnings, including cumulative 
  translation adjustments of $1,194,000 
  (1995) and $326,000 (1996)                   70,517,000           74,465,000
Unearned compensation                          (1,716,000)          (1,515,000)
Unrealized loss on marketable securities           12,000                4,000
                                             ------------         ------------
Total stockholders' equity                    109,530,000          112,055,000
                                             ------------         ------------
TOTAL                                        $207,690,000         $203,026,000
                                             ------------         ------------
                                             ------------         ------------

            See the accompanying notes to consolidated financial statements

<PAGE>

                        HERBALIFE INTERNATIONAL, INC.
                      CONSOLIDATED STATEMENTS OF INCOME
                                 (Unaudited)

                                                      Three Months Ended
                                               March 31, 1995     March 31, 1996
                                               --------------     --------------
Retail sales                                   $ 229,166,000      $ 276,572,000

Less distributor allowances on product 
  purchases                                     (107,554,000)      (130,349,000)
                                               --------------     --------------

Net sales                                        121,612,000        146,223,000

Cost of sales                                     34,459,000         40,466,000

Royalty overrides                                 34,704,000         43,218,000
                                               --------------     --------------

Operating margin                                  52,449,000         62,539,000

Marketing, distribution and administrative 
  expenses                                        42,951,000         48,704,000

Interest income - net                               (583,000)          (918,000)
                                               --------------     --------------

Income before income taxes                        10,081,000         14,753,000

Income taxes                                       3,780,000          5,533,000
                                               --------------     --------------

NET INCOME                                     $   6,301,000      $   9,220,000
                                               --------------     --------------
                                               --------------     --------------

EARNINGS PER SHARE                                     $0.21              $0.30
                                               --------------     --------------
                                               --------------     --------------

WEIGHTED AVERAGE SHARES OUTSTANDING               30,381,101         31,011,269
                                               --------------     --------------
                                               --------------     --------------

CASH DIVIDENDS PER COMMON SHARE                        $0.22              $0.15
                                               --------------     --------------
                                               --------------     --------------


            See the accompanying notes to consolidated financial statements

<PAGE>

                        HERBALIFE INTERNATIONAL, INC.
                    CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (Unaudited)

                                                        Three Months Ended
                                                 March 31, 1995   March 31, 1996
                                                 --------------   --------------
CASH FLOWS FROM OPERATING ACTIVITIES
Net income                                        $ 6,301,000       $ 9,220,000
Adjustments to reconcile net income to 
  net cash provided by operating activities:
    Depreciation and amortization                   1,913,000         2,289,000
    Deferred income taxes                            (664,000)          684,000
    Amortization of unearned compensation             293,000           201,000
    Foreign exchange gain                          (2,357,000)         (137,000)
    Other                                             105,000             7,000
    Changes in operating assets and liabilities:
      Receivables                                   6,102,000        (1,168,000)
      Inventories                                     872,000        (2,763,000)
      Prepaid expenses and other current assets     3,075,000        (2,051,000)
      Other assets                                 (1,513,000)          632,000
      Accounts payable                             (3,229,000)       (1,997,000)
      Royalty overrides                             1,270,000        (4,597,000)
      Accrued expenses                             (2,181,000)        7,614,000
      Advance sales deposits                       (1,330,000)       (7,436,000)
      Income taxes payable                         12,776,000         1,891,000
                                                 --------------   --------------
NET CASH PROVIDED BY OPERATING ACTIVITIES          21,433,000         2,389,000
                                                 --------------   --------------

CASH FLOWS FROM INVESTING ACTIVITIES
   Purchases of property                           (1,969,000)       (2,776,000)
   Proceeds from sale of property                     228,000
   Changes in marketable securities                 4,506,000         3,622,000
                                                 --------------   --------------
NET CASH PROVIDED BY INVESTING ACTIVITIES           2,765,000           846,000
                                                 --------------   --------------

CASH FLOWS FROM FINANCING ACTIVITIES
   Dividends paid                                  (6,597,000)       (4,480,000)
   Additions to loans payable                         596,000           207,000
   Principal payments on loans payable               (350,000)         (490,000)
   Exercise of stock options                           73,000           105,000
   Stock repurchases                                                 (1,839,000)
   Other                                                                 98,000
                                                 --------------   --------------
NET CASH USED BY FINANCING ACTIVITIES              (6,278,000)       (6,399,000)
                                                 --------------   --------------
EFFECT OF EXCHANGE RATE CHANGES ON CASH                58,000          (664,000)
                                                 --------------   --------------
NET CHANGE IN CASH AND CASH EQUIVALENTS            17,978,000        (3,828,000)

CASH AND CASH EQUIVALENTS AT THE BEGINNING 
  OF THE PERIOD                                    34,284,000        69,176,000
                                                 --------------   --------------
CASH AND CASH EQUIVALENTS AT THE END OF THE 
  PERIOD                                          $52,262,000       $65,348,000
                                                 --------------   --------------
                                                 --------------   --------------


            See the accompanying notes to consolidated financial statements

<PAGE>

                        HERBALIFE INTERNATIONAL, INC.
                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. INTERIM FINANCIAL INFORMATION

The unaudited interim financial information of Herbalife International, Inc. 
(the "Company") has been prepared in accordance with Article 10 of the 
Securities and Exchange Commission's Regulation S-X. In the opinion of 
management, the accompanying interim financial information contains all 
adjustments, consisting of normal recurring adjustments, necessary to present 
fairly the Company's financial statements as of March 31, 1996 and for the 
three month periods ended March 31, 1995 and 1996.

2. CONTINGENCIES

In January 1995, the Company and certain of its officers and directors were 
served with three complaints alleging violation of federal securities laws. 
In March 1995, the Court consolidated the three complaints. In January 1996, 
the court dismissed in its entirety the plaintiffs' consolidated complaint. 
In February 1996, the plaintiffs filed a notice of appeal of the court's 
order of dismissal. The Company has certain indemnity obligations to the 
named officers and directors. The Company has directors and officers' 
liability insurance which, subject to certain customary exceptions and 
exclusions, is expected to cover a portion or all of any such obligations 
less the Company's self-retention amount. Based upon review of the 
allegations of the complaints, the court's dismissal of the complaints and 
analysis by litigation counsel, the Company believes that it has substantial 
and meritorious defenses to the asserted claims and is vigorously contesting 
these claims.

The Company's French subsidiary has been subject to a tax audit by French tax 
authorities, who are proposing that significant value added, withholding, and 
income taxes are due. The Company and its tax advisors believe that the 
Company has substantial defenses and the Company is vigorously contesting 
these and other potential assessments. However, the ultimate resolution of 
this matter may take several years.

Furthermore, the Company is from time to time engaged in routine litigation 
incident to the conduct of its business. The Company regularly reviews all 
pending litigation matters in which it is involved and, estimating the impact 
of such litigation matters, establishes reserves considered appropriate by 
management. The Company's estimates of the impact of these matters may change 
as the matters progress and are ultimately resolved.


<PAGE>

                        HERBALIFE INTERNATIONAL, INC.

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
         RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

Throughout this report "retail sales" are determined as the gross sales 
amounts reflected on the Company's invoices to its distributors. The Company 
does not receive the amount reported as "retail sales", and the Company does 
not monitor the actual retail prices charged for the Company's products. "Net 
sales" represent the actual purchase prices paid to the Company by its 
distributors, after giving effect to distributor discounts (referred to as 
"distributor allowances"), which total approximately 50% of suggested retail 
sales prices. The Company receives its net sales price in cash or through 
credit card payments upon receipt of orders from distributors. The Company's 
"operating margin" consists of net sales less (i) "cost of sales," consisting 
of the prices paid by the Company to its manufacturers for products and costs 
related to product shipments, foreign duties and tariffs and similar 
expenses, and (ii) "royalty overrides," currently consisting of (a) royalties 
(5% to 15%) and bonuses (up to 6%) on the suggested retail sales prices of 
products earned by qualifying distributors on the sales of other distributors 
within their distributor organizations, and (b) the President's Team Bonus 
payable to certain of the Company's most senior distributors in the aggregate 
amount of up to an additional 1% of product retail sales. Royalty overrides 
as reported in the Consolidated Statements of Income are net of a handling 
fee (6% of retail sales) charged by the Company to its distributors on 
purchases of products from the Company.

The Company's use of "retail sales" in reporting financial and operating data 
reflects the fundamental role of "retail sales" in the Company's accounting 
systems, internal controls and operations, including the basis upon which 
distributor bonuses are paid. The retail sales price of the Company's 
products is reflected in distributor invoices as the price charged to 
distributors together with, in most cases, a deduction for the corresponding 
distributor allowance. The retail sales price is used by the Company to 
calculate, among other things, royalty overrides and "volume points" earned 
by distributors. Volume points are point values assigned to each of the 
Company's products that are equal in all countries, and are used as a 
supervisor qualification criteria. In addition, management relies upon 
"retail sales" data reflected in daily sales reports to monitor results of 
operations in each of the Company's markets.

The significance of the Company's "net sales" is to reflect, generally, the 
prices actually received by the Company after deducting the basic distributor 
allowance, but before deducting royalty overrides and bonuses. The ratio of 
the Company's "retail sales" to "net sales" is relatively constant because 
distributor allowances historically total approximately 50% of suggested 
retail sales prices. Accordingly, factors that affect "retail sales" 
generally have a corresponding and proportionate effect on "net sales." To 
the extent the ratio of "retail sales" to "net sales" varies from period to 
period, such variances have resulted principally from sales of the Company's 
distributor kits and other educational and promotional materials, for which 
there are no distributor allowances. Sales of such items initially decreased 
and thereafter stabilized as a percentage of total retail sales since 1991, 
but such decreases have not had a material impact on the ratio of the 
Company's "retail sales" to "net sales" or on the Company's operating margin.

The Company's results of operations for the periods described below are not 
necessarily indicative of results of operations for future periods, which 
depend upon numerous factors including the Company's ability in the future to 
enter new markets and introduce additional and new products into its markets.

COMPARISON OF FIRST QUARTER 1996 TO 1995

Retail sales for the three months ended March 31, 1996 increased 20.7% to 
$276.6 million compared to the corresponding prior year period. Regionally, 
retail sales in the first quarter of 1996 compared to the first quarter of 
1995 increased 113.3% and 18.7% in Asia/Pacific Rim and The Americas, 
respectively; and remained flat in Europe on a year to year basis. In 
Asia/Pacific Rim, retail sales increased from $25.0 million in 1995 to $53.3 
million in 1996. Retail sales in The Americas of $98.7 million in 1995 
increased to $117.1 million in 1996. In Europe, retail sales were $105.5 
million in 1995 compared to $106.1 million in 1996.

In The Americas, combined retail sales in 1996 increased $18.4 million, or 
18.7%, when compared to 1995. This was primarily due to the opening of Brazil 
in October 1995 which reported retail sales of $25.4 million in 1996, 
partially offset by a sales decline in Argentina and Mexico totaling $6.7 
million. Within The Americas, U.S. retail sales accounted for $81.9 million or

<PAGE>


                        HERBALIFE INTERNATIONAL, INC.

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
         RESULTS OF OPERATIONS

RESULTS OF OPERATIONS (CONTINUED)

COMPARISON OF FIRST QUARTER 1996 TO 1995 (CONTINUED)

29.6% of total worldwide retail sales in 1996, compared to $84.7 million or 
37.0% of total worldwide retail sales in 1995. The decline in U.S. retail 
sales as a percentage of worldwide retail sales primarily resulted from sales 
growth of foreign markets, namely Japan, Brazil and Russia.

The growth in Asia/Pacific Rim primarily resulted from increased retail sales 
in Japan of $33.4 million, or 379% as compared to the same period of the 
prior year, and retail sales of $2.3 million in Taiwan, which opened in July 
1995. The retail sales growth in Asia/Pacific Rim was partially offset by 
decreased sales of $5.1 million in the Philippines.

In Europe, retail sales in new countries together with increased retail sales 
in Poland and Sweden were offset by retail sales decreases in existing 
countries, primarily Germany. The decrease in Germany of $30.1 million was 
due in part to the continued suspension of sales of Thermojetics-R- Instant 
Herbal Beverage in that country which began in July 1995. The suspension led 
to an increase in product returns and distributor resignations, as well as a 
decline in sales of other products. The Company believes that a significant 
factor affecting these markets has been the opening of other new markets 
within the same geographic region or with the same or similar language or 
cultural bases, and the inclination of some distributors to focus their 
attention on business opportunities provided by new markets which can have a 
negative impact on existing markets.

Operating margin increased 19.2% to $62.5 million in 1996 from $52.4 million 
in 1995. As a percentage of retail sales, operating margin for 1996 decreased 
modestly to 22.6% from 22.9% in 1995. This decrease is due to an increase in 
royalty overrides as a percentage of retail sales resulting from a 
modification to the marketing plan made in June 1995, which increased the 
royalties earned by distributors and increased bonuses payable to certain of 
the Company's senior distributors.

Marketing, distribution and administrative expenses as a percentage of retail 
sales decreased to 17.6% in 1996 from 18.7% in 1995. These expenses increased 
13.4% to $48.7 million in 1996 from $43.0 million in 1995. Distribution 
expenses increased primarily due to facility and staff expansions in Japan 
and new country openings in Brazil, South Africa, and Taiwan. Administrative 
expenses increased due to continued emphasis on government and media 
relations and increased compensation and other costs related primarily to the 
expansion into additional countries. In addition, foreign exchange losses 
were $0.2 million in 1996 compared to a gain of $1.6 million in the prior 
year. Selling expenses decreased as a result of a revised format in which 
sales events are scheduled throughout the year rather than concentrated in a 
particular period.

Income taxes increased $1.7 million to $5.5 million in 1996 from $3.8 million 
in 1995. As a percentage of pre-tax income, income taxes remained constant at 
37.5%.

Net income increased 46.3% to $9.2 million in 1996 from $6.3 million in 1995 
as a result of the factors described above. The increase primarily resulted 
from increased retail sales and a decrease in marketing, distribution and 
administrative expenses as a percentage of retail sales.

LIQUIDITY AND CAPITAL RESOURCES

The Company has historically met its working capital and capital expenditure 
requirements, including funding for expansion of operations, through net cash 
provided by operating activities. For the three months ended March 31, 1996, 
net cash provided by operating activities was $2.4 million, compared to $21.4 
million for the three months ended March 31, 1995. The decrease primarily 
resulted from (i) non-recurring 1995 income tax refunds; (ii) comparably 
higher receivable balances primarily resulting from new and existing country 
expansion as compared to significantly lower receivables in the prior year, 
(iii) reductions in advanced sales deposit balances and royalty override 
accruals primarily due to timing issues, and (iv) increased inventory 
balances resulting primarily from new country expansion and new product 
introductions. These

<PAGE>

                        HERBALIFE INTERNATIONAL, INC.

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
         RESULTS OF OPERATIONS

RESULTS OF OPERATIONS (CONTINUED)

LIQUIDITY AND CAPITAL RESOURCES (CONTINUED)

reductions were partially offset by increased net income and additional 
liquidity provided by higher accounts payable and accrued expense balances.

Capital expenditures for the three months ended March 31, 1996 were $2.8 
million compared to $2.0 million for the corresponding prior year period. The 
majority of the 1996 expenditures were made to expand office facilities and 
equipment to support growth. For 1996, the Company is planning to invest up 
to $7 million in management information systems including hardware and 
software. In connection with its entry into each new market, the Company 
funds inventory requirements and typically establishes either a full-service 
distribution center, sales office, a fulfillment center or compliance office, 
or a combination of the foregoing. While the capital requirements associated 
with entry into new markets vary, the Company estimates that approximately $7 
million will be required for pre-opening expenses and capital expenditures 
associated with its 1996 new market expansion activities.

Stockholders' equity increased $2.5 million to $112.1 million during the 
three months ended March 31, 1996. In 1996, net income of $9.2 million was 
partially offset by $4.5 million of dividends declared and stock repurchases 
of $1.8 million. The payment of dividends is determined by the Board of 
Directors at its discretion and the amounts of dividends declared and paid in 
future quarters will depend, among other factors, on increased levels of 
profitability, as well as other planned uses of the Company's cash resources.

On January 12, 1996, the Company announced that its Board of Directors had 
approved a share repurchase program pursuant to which up to $5 million could 
be expended to repurchase shares of the Company's common stock. As of April 
30, 1996, the Company had expended $3.3 million to make repurchases of its 
shares in the public market.

In total, cash and cash equivalents totaled $65.3 million at March 31, 1996 
compared to $69.2 million at December 31, 1995. At March 31, 1996, the 
Company's cash, cash equivalents and marketable securities aggregate balance 
was $96.8 million, which represents a $7.5 million decrease from the balance 
as of December 31, 1995.

The Company has not been subjected to material price increases by its 
suppliers for several years. The Company believes that it has the ability to 
respond to a portion or possibly all of any price increases by raising the 
price of its products. Purchases by the Company from its suppliers are made 
in U.S. dollars, while sales to distributors are generally made in local 
currencies. Consequently, strengthening of the U.S. dollar versus a foreign 
currency can have a negative impact on operating margins and can generate 
transaction losses on intercompany transactions. The Company enters into 
forward exchange contracts to manage its foreign exchange risk on 
intercompany transactions.


<PAGE>

                          PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

      See discussion under "Legal Proceedings" in the Company's Annual Report 
on Form 10-K for the fiscal year ended December 31, 1995 and in footnote 
three to the Financial Statements included in Item 1 of this document.

ITEM 2. CHANGES IN SECURITIES

      None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

      None.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

      None.

ITEM 5. OTHER INFORMATION

      None.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

      (a) EXHIBITS

                        HERBALIFE INTERNATIONAL, INC.
                                EXHIBIT INDEX
- --------------------------------------------------------------------------------
Exhibit 
Number      Description                                      Page No./(Footnote)
- --------------------------------------------------------------------------------
3.1         Articles of Incorporation                                (2)
3.2         Articles of Amendment to the Articles of 
            Incorporation dated December 10, 1986                    (2)
3.3         Articles of Amendment to the Articles of 
            Incorporation dated November 22, 1989                    (2)
3. 4        Certificate of Determination relating to the 
            Company's Senior Convertible Preferred Stock 
            dated February 11, 1993                                  (7)
3.5         Certificate of Amendment to Articles of
            Incorporation dated May 14, 1993                         (7)
3.6         Amended and Restated Bylaws                              (7)
4.1         Form of Common Stock Certificate                         (7)
10.1        Agreement between Herbalife International of 
            America, Inc. and D&F Industries, Inc. dated 
            May 12, 1993                                             (7)
10.2        Agreement between Herbalife International of 
            America, Inc. and Raven Industries, Inc. dated 
            May 12, 1993                                             (7)
10.3        Agreement between Herbalife International of 
            America, Inc. and Dynamic Products, Inc. dated 
            May 12, 1993                                             (7)
10.4        Master Lease between the Company and Trizec 
            Properties, Inc. dated July 17, 1991                     (4)
10.5        Equipment Lease Agreement between the Company 
            and Hewlett Packard dated May 21, 1992                   (5)
10.6        Final Judgment and Permanent Injunction, entered 
            into on October, 1986 by the parties to that 
            action  entitled People of the State of 
            California, et al., v Herbalife International, 
            Inc. et al., Case No. 92767 in the Superior 
            Court of the State of  California for the County
            of Santa Cruz                                            (1)
10.7        Permitting Agreement between the Company and 
            Nippon Herbalife K.K. effective July 27, 1988            (3)
10. 8       Exclusive License Agreement between the Company
            and Nippon Herbalife K.K. dated August 25, 1988          (3)
10.9        First Addendum to Exclusive License Agreement 
            between the  Company and Nippon Herbalife K.K. 
            dated April 10, 1991                                     (7)

<PAGE>

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K (CONTINUED)
- --------------------------------------------------------------------------------
Exhibit 
Number      Description                                      Page No./(Footnote)
- --------------------------------------------------------------------------------
10.10       Second Addendum to Exclusive License Agreement 
            dated between the Company and Nippon Herbalife 
            K.K. dated May 22, 1992                                  (5)
10.11       The Company's 1988 Incentive Plan                        (1)
10.12       The Company's 1991 Stock Option Plan, as amended       (6),(12)
10.13       The Company's Executive Incentive Compensation 
            Plan, as amended                                       (7),(12)
10.14       Form of Individual Participation Agreement 
            relating to the Company's Executive Compensation 
            Plan                                                     (7)
10.15       Employment Agreement between the Company and 
            Norman Friedmann dated August 1,  1992                   (5)
10.17       Amendment to Employment Agreement between the 
            Company and Norman Friedmann dated July 27, 1993         (7)
10.18       Amendment to Employment Agreement between the 
            Company and David Addis dated June 29, 1993              (7)
10.19       Form of Letter Agreement between the 
            Compensation Committee of the Board of Directors
            of the Company and Mark Hughes                           (7)
10.20       Form of Indemnity Agreement between the Company 
            and certain officers and directors of the Company        (7)
10.21       Trust Agreement among the Company, Citicorp 
            Trust, N.A. and certain officers and directors 
            of the Company                                           (7)
10.22       Form of Stock Appreciation Rights Agreement 
            between the Company and certain directors of the 
            Company                                                  (7)
10.23       1994 Performance Based Annual Incentive 
            Compensation Plan                                      (9),(12)
10.24       Form of Promissory Note for Advances under the 
            Company's 1994 Performance Based Annual 
            Incentive Compensation Plan                             (10)
10.25       Employment Agreement between the Company and 
            Chris Pair dated April 3, 1994                           (8)
10.26       Deferred Compensation Agreement between the 
            Company and Michael Rosen                               (10)
10.27       Office lease agreement between the Company and 
            State Teacher's Retirement System, dated 
            July 20, 1995                                           (11)
10.28       Form of stock appreciation rights agreements 
            between the Company and certain directors of 
            the Company                                             (11)
10.29       The Company's Senior Executive Deferred 
            Compensation Plan, effective January 1, 1996            (11)
10.30       The Company's Management Deferred Compensation 
            Plan, effective January 1, 1996                         (11)
10.31       Matter Trust Agreement between the company and 
            Imperial Trust Company, Inc., effective 
            January 1, 1996                                         (11)
10.32       The Company's 401K Plan                                 (11)
21          List of subsidiaries of the Company                     (11)
27          Financial Data Schedule (via EDGAR)                     (13)
- --------------------------------------------------------------------------------

<PAGE>

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K (CONTINUED)

   FOOTNOTES

    (1)  Incorporated by reference to the Company's
         Annual Report on Form 10-K for the year ended December 31, 1987.

    (2)  Incorporated by reference to the Company's
         Annual Report on Form 10-K for the year ended December 31, 1989.

    (3)  Incorporated by reference to the Company's
         Annual Report on Form 10-K for the year ended December 31, 1990.

    (4)  Incorporated by reference to the Company's
         Annual Report on Form 10-K for the year ended December 31, 1991.

    (5)  Incorporated by reference to the Company's
         Annual Report on Form 10-K for the year ended December 31, 1992.

    (6)  Incorporated by reference to the Company's
         definitive Proxy Statement relating to its annual meeting of
         shareholders held May 20, 1993.
 
    (7)  Incorporated by reference to the Company's
         Registration Statement on Form S-1 (No. 33-66576) declared
         effective by the Securities and Exchange Commission on October 8, 1993.

    (8)  Incorporated by reference to the Company's Quarterly Report on 
         Form 10-Q for the three months ended June 30, 1994.

    (9)  Incorporated by reference to the Company's Definitive Proxy 
         Statement relating to its 1994 Annual Meeting of Stockholders.

   (10)  Incorporated by reference to the Company's Annual Report on 
         Form 10-K for the year ended December 31, 1994.

   (11)  Incorporated by reference to the Company's Annual Report on 
         Form 10-K for the year ended December 31, 1995.

   (12)  Form of the amended and restated plan, to be submitted for 
         shareholder approval at the 1996 Annual Meeting, incorporated
         by reference to the Company's Proxy Statement relating to its 
         1996 Annual Meeting of Shareholders.

   (13)  Filed herewith.

  (b) REPORTS ON FORM 8-K

  None.

<PAGE>

                                  SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
Registrant has duly caused this report to be signed on its behalf by the 
undersigned, thereunto duly authorized.



Date: May 15, 1996


                        HERBALIFE INTERNATIONAL, INC.
                                 (Registrant)

                            By: /s/ TIMOTHY GERRITY
                                -------------------
                                  Timothy Gerrity
                           Executive Vice President and
                              Chief Financial Officer





<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                      65,348,000
<SECURITIES>                                31,420,000
<RECEIVABLES>                               19,494,000
<ALLOWANCES>                                         0
<INVENTORY>                                 43,170,000
<CURRENT-ASSETS>                           174,543,000
<PP&E>                                      42,288,000
<DEPRECIATION>                              24,293,000
<TOTAL-ASSETS>                             203,026,000
<CURRENT-LIABILITIES>                       86,361,000
<BONDS>                                      1,533,000
                                0
                                          0
<COMMON>                                       299,000
<OTHER-SE>                                 111,756,000
<TOTAL-LIABILITY-AND-EQUITY>               203,026,000
<SALES>                                    146,223,000
<TOTAL-REVENUES>                           276,572,000
<CGS>                                       40,466,000
<TOTAL-COSTS>                               83,684,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                             14,753,000
<INCOME-TAX>                                 5,533,000
<INCOME-CONTINUING>                          9,220,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 9,220,000
<EPS-PRIMARY>                                     0.30
<EPS-DILUTED>                                     0.30
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission